Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 25 studies | 25% ± 10% | |
endothelial cell | 19 studies | 26% ± 7% | |
microglial cell | 14 studies | 44% ± 14% | |
pericyte | 8 studies | 23% ± 4% | |
myeloid cell | 8 studies | 24% ± 6% | |
vein endothelial cell | 8 studies | 25% ± 17% | |
non-classical monocyte | 7 studies | 24% ± 12% | |
fibroblast | 7 studies | 22% ± 4% | |
dendritic cell | 7 studies | 26% ± 15% | |
monocyte | 6 studies | 21% ± 6% | |
classical monocyte | 6 studies | 22% ± 9% | |
astrocyte | 5 studies | 23% ± 7% | |
conventional dendritic cell | 4 studies | 23% ± 5% | |
myofibroblast cell | 4 studies | 27% ± 4% | |
smooth muscle cell | 4 studies | 19% ± 1% | |
connective tissue cell | 4 studies | 21% ± 4% | |
endothelial cell of lymphatic vessel | 4 studies | 20% ± 1% | |
capillary endothelial cell | 3 studies | 20% ± 3% | |
mononuclear phagocyte | 3 studies | 18% ± 1% | |
endothelial cell of vascular tree | 3 studies | 31% ± 16% | |
endothelial cell of artery | 3 studies | 19% ± 1% | |
alveolar macrophage | 3 studies | 28% ± 8% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1826.20 | 459 / 459 | 97% | 22.70 | 1086 / 1118 |
skin | 100% | 4186.61 | 1809 / 1809 | 95% | 23.65 | 448 / 472 |
uterus | 100% | 1536.29 | 170 / 170 | 93% | 17.56 | 425 / 459 |
lung | 100% | 2277.42 | 577 / 578 | 92% | 15.42 | 1057 / 1155 |
esophagus | 100% | 2536.89 | 1445 / 1445 | 89% | 19.05 | 163 / 183 |
brain | 87% | 765.69 | 2292 / 2642 | 100% | 29.81 | 704 / 705 |
thymus | 99% | 1314.41 | 649 / 653 | 81% | 7.52 | 489 / 605 |
kidney | 85% | 639.17 | 76 / 89 | 79% | 10.68 | 711 / 901 |
ovary | 89% | 745.43 | 160 / 180 | 72% | 6.37 | 308 / 430 |
bladder | 100% | 1300.48 | 21 / 21 | 57% | 7.43 | 285 / 504 |
stomach | 85% | 1212.44 | 304 / 359 | 67% | 9.26 | 193 / 286 |
intestine | 97% | 1622.91 | 935 / 966 | 48% | 4.95 | 255 / 527 |
prostate | 90% | 767.73 | 221 / 245 | 46% | 3.16 | 232 / 502 |
adrenal gland | 86% | 572.48 | 222 / 258 | 40% | 3.32 | 93 / 230 |
pancreas | 16% | 86.84 | 51 / 328 | 86% | 10.68 | 153 / 178 |
adipose | 100% | 2187.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2892.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1717.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.33 | 44 / 45 |
heart | 94% | 972.24 | 813 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 13.34 | 26 / 29 |
peripheral blood | 64% | 627.26 | 592 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 2.78 | 34 / 80 |
liver | 24% | 132.93 | 54 / 226 | 17% | 1.26 | 71 / 406 |
muscle | 19% | 102.52 | 152 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0021762 | Biological process | substantia nigra development |
GO_0044297 | Cellular component | cell body |
GO_0005834 | Cellular component | heterotrimeric G-protein complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GNB4 |
Protein name | G protein subunit beta 4 Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4) |
Synonyms | |
Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. |
Accessions | ENST00000468623.6 A0A6Q8PFV8 ENST00000466899.6 ENST00000675901.1 ENST00000674713.1 A0A6Q8PFE0 ENST00000232564.8 A0A6Q8PFW8 A0A6Q8PG88 ENST00000674927.1 ENST00000465153.2 Q9HAV0 H7C5J5 ENST00000497513.1 C9JD14 ENST00000676128.1 A0A7I2S2S9 ENST00000674862.1 |